According to AC Immune's latest financial reports the company has $0.18 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $0.18 B | 49.49% |
2023-12-31 | $0.12 B | -7.64% |
2022-12-31 | $0.13 B | -38.83% |
2021-12-31 | $0.21 B | -15.34% |
2020-12-31 | $0.25 B | -14% |
2019-12-31 | $0.29 B | 57.16% |
2018-12-31 | $0.18 B | 48.41% |
2017-12-31 | $0.12 B | -14.51% |
2016-12-31 | $0.14 B | 92.92% |
2015-12-31 | $77.45 M | 2215.91% |
2014-12-31 | $3.34 M |